AmSurg Upgraded To Outperform
Recently, we upgraded AmSurg Corporation (NASDAQ:AMSG) to Outperform with a target price of $25.00. AmSurg reported EPS of 41 cents in the second quarter of fiscal 2011, in line with both the Zacks Consensus Estimate and the year-ago quarter earnings. After a sluggish fiscal 2010, mainly impacted by reimbursement issues, higher interest expenses and tax [...]
Recently, we upgraded AmSurg Corporation (NASDAQ:AMSG) to Outperform with a target price of $25.00.
AmSurg reported EPS of 41 cents in the second quarter of fiscal 2011, in line with both the Zacks Consensus Estimate and the year-ago quarter earnings.
After a sluggish fiscal 2010, mainly impacted by reimbursement issues, higher interest expenses and tax rate, AmSurg reported revenues of $188.7 million, up 7.4% from $175.7 million reported in the year-ago period.
The upside was primarily attributable … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards